Topical acetone treatment induces neurogenic oedema on the sensitized mouse ear: An in vivo study using transient receptor potential vanilloid 1 (TRPV1) receptor knockout mice

Inflammation Research

Volumn 56, Issue 11, 2007, Pages 459-467

  Pozsgai, G ^a   Sandor K ^a   Perkecz, A ^a   Szolcsanyi J ^a   Helyes, Z ^a   Brain, S D ^b   Pinter E ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

IL 1 ; Phorbol 12 myristate 13 acetate; Prostanoids; Resiniferatoxin; TRPV1

Indexed keywords

ACETONE; CAPSAICIN; IBUPROFEN; INTERLEUKIN 1 ANTIBODY; INTERLEUKIN 1BETA; MYELOPEROXIDASE; PHORBOL 13 ACETATE 12 MYRISTATE; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

ANGIONEUROTIC EDEMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; EAR; ENZYME ACTIVITY; HISTOPATHOLOGY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN DETERMINATION; SENSORY NERVE CELL; SKIN SENSITIZATION;

ACETONE; ADMINISTRATION, CUTANEOUS; AFFERENT PATHWAYS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES; CAPSAICIN; DITERPENES; DRUG SYNERGISM; EAR; EDEMA; IBUPROFEN; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEROXIDASE; RECEPTORS, SENSORY; TETRADECANOYLPHORBOL ACETATE; TRPV CATION CHANNELS;

EID: 38549163766     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-7065-7     Document Type: Article

References (39)

1. Carlson RP, O'Neill-Davis L, Chang J, Lewis AJ. Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions 1985; 17: 197-204.
2. De Young LM, Kheifets JB, Ballaron SJ, Young JM. Edema and cell infiltration in the phorbol ester-treated mouse ear are temporally separate and can be differentially modulated by pharmacologic agents. Agents Actions 1989; 26: 335-41.
3. Garrido G, Gonzalez D, Lemus Y, Garcia D, Lodeiro L, Quintero G et al. In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG). Pharmacol Res 2004; 50: 143-9.
4. Huang MT, Liu Y, Ramji D, Lo CY, Ghai G, Dushenkov S et al. Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13- acetate-induced inflammation and arachidonic acid metabolism in mouse ears. Mol Nutr Food Res 2006; 50: 115-22.
5. Kuchera S, Barth H, Jacobson P, Metz A, Schaechtele C, Schrier D. Anti-inflammatory properties of the protein kinase C inhibitor, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H- pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model. Agents Actions 1993; 39 Spec No: C169-73.
6. Young JM, Wagner BM, Spires DA. Tachyphylaxis in 12-0- tetradecanoylphorbol acetate- and arachidonic acid-induced ear edema. J Invest Dermatol 1983; 80: 48-52.
7. Bermejo BP, Abad Martinez MJ, Silvan Sen AM, Sanz GA, Fernandez ML, Sanchez CS et al. In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci 1998; 63: 1147-56.
8. Silvan AM, Abad MJ, Bermejo P, Villar A. Inhibition by hydroxyachillin, sesquiterpene lactone from Tanacetum microphyllum, of PMA-induced mouse ear oedema. Inflamm Res 1996; 45: 289-92.
9. Szallasi A, Blumberg PM. Neurogenic component of phorbol ester-induced mouse skin inflammation. Cancer Res 1989; 49: 6052-7.
10. Szolcsanyi J. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. Prog Brain Res 1996; 113: 343-59.
11. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389: 816-24.
12. Wang H, Woolf CJ. Pain TRPs. Neuron 2005; 46: 9-12.
13. Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P et al. Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 2000; 405: 183-7.
14. Amadesi S, Nie J, Vergnolle N, Cottrell GS, Grady EF, Trevisani M et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 2004; 24: 4300-12.
15. Garcia-Martinez C, Humet M, Planells-Cases R, Gomis A, Caprini M, Viana F et al. Attenuation of thermal nociception and hyperalgesia by VR1 blockers. Proc Natl Acad Sci U S A 2002; 99: 2374-9.
16. Szolcsanyi J, Petho G. History of ion channels in the pain sensory system. In: Oh U editor. The Nociceptive Membrane. San Diego: Academic Press, 2006: 21-72.
17. Tominaga M, Wada M, Masu M. Potentiation of capsaicin receptor activity by metabotropic ATP receptors as a possible mechanism for ATP-evoked pain and hyperalgesia. Proc Natl Acad Sci U S A 2001; 98: 6951-6.
18. Helyes Z, Pinter E, Nemeth J, Szolcsanyi J. Pharmacological targets for the inhibition of neurogenic inflammation. Curr Med Chem 2003; 2: 191-218.
19. Pinter E, Szolcsanyi J. Plasma extravasation in the skin and pelvic organs evoked by antidromic stimulation of the lumbosacral dorsal roots of the rat. Neuroscience 1995; 68: 603-14.
20. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA. Specifi c involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999; 23: 617-24.
21. Chuang HH, Prescott ED, Kong H, Shields S, Jordt SE, Basbaum AI et al. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001; 411: 957-62.
22. Varga A, Bolcskei K, Szoke E, Almasi R, Czeh G, Szolcsanyi J et al. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo. Neuroscience 2006; 140: 645-57.
23. Bolcskei K, Helyes Z, Szabo A, Sandor K, Elekes K, Nemeth J et al. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 2005; 117: 368-76.
24. Ferreira J, Triches KM, Medeiros R, Calixto JB. Mechanisms involved in the nociception produced by peripheral protein kinase c activation in mice. Pain 2005; 117: 171-81.
25. Gabor M, Razga Z. Development and inhibition of mouse ear oedema induced with capsaicin. Agents Actions 1992; 36: 83-6.
26. Griswold DE, Martin LD, Badger AM, Breton J, Chabot-Fletcher M. Evaluation of the cutaneous anti-inflammatory activity of azaspiranes. Inflamm Res 1998; 47: 56-61.
27. Saade NE, Al Amin H, Chalouhi S, Baki SA, Jabbur SJ, Atweh SF. Spinal pathways involved in supraspinal modulation of neuropathic manifestations in rats. Pain 2006; 126: 280-93.
28. Colburn RW, Lubin ML, Stone DJ Jr, Wang Y, Lawrence D, D'Andrea MR et al. Attenuated cold sensitivity in TRPM8 null mice. Neuron 2007; 54: 379-86.
29. Voets T, Owsianik G, Nilius B. TRPM8. Handb Exp Pharmacol 2007; 179: 329-44.
30. Ferreira SH, Lorenzetti BB, Bristow AF, Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988; 334: 698-700.
31. Follenfant RL, Nakamura-Craig M, Henderson B, Higgs GA. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br J Pharmacol 1989; 98: 41-3.
32. Herbert MK, Hering S, Holzer P. Interleukin 1 beta, but not tumor necrosis factor, enhances neurogenic vasodilatation in the rat skin: involvement of nitric oxide. Can J Physiol Pharmacol 1995; 73: 1075-9.
33. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8: 1314-25.
34. Pinter E, Than M, Chu DQ, Fogg C, Brain SD. Interaction between interleukin 1beta and endogenous neurokinin 1 receptor agonists in mediating plasma extravasation and neutrophil accumulation in the cutaneous microvasculature of the rat. Neurosci Lett 2002; 318: 13-6.
35. Herbert MK, Holzer P. Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin. Br J Pharmacol 1994; 111: 681-6.
36. Inoue A, Ikoma K, Morioka N, Kumagai K, Hashimoto T, Hide I et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem 1999; 73: 2206-13.
37. Perkins MN, Kelly D. Interleukin-1 beta induced-desArg9bradykinin- mediated thermal hyperalgesia in the rat. Neuropharmacology 1994; 33: 657-60.
38. Copray JC, Mantingh I, Brouwer N, Biber K, Kust BM, Liem RS et al. Expression of interleukin-1 beta in rat dorsal root ganglia. J Neuroimmunol 2001; 118: 203-11.
39. Obreja O, Rathee PK, Lips KS, Distler C, Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J 2002; 16: 1497-1503.